Category: News
-
Date:
Drugs of Abuse Testing Market to Reach USD 18.7 Billion by 2031, Growing at a 13.5% CAGR
The global Drugs of Abuse Testing market was valued at USD 5.9 billion in 2022 and is projected to reach USD 18.7…
-
Date:
Sinusitis Treatment Market to Reach USD 3.5 Billion by 2031 as Key Players Drive Innovation in Nasal Therapies and Antibiotics – Key Players: Pfizer Inc., GlaxoSmithKline plc, Sanofi S.A., Bayer AG
The global sinusitis treatment market was valued at USD 2.1 billion in 2022 and is projected to reach USD 3.5 billion by…
-
Date:
Oncolytic Virus Immunotherapy Market to Reach USD 572.2 Mn by 2031, Led by Key Players Such as Amgen, Takara Bio Inc., and SillaJen, Inc.
The global Oncolytic Virus Immunotherapy Market was valued at USD 110.2 Mn in 2022 and is projected to witness strong growth, reaching…
-
Date:
Global Neuroprotection Market to Reach US$ 60.1 Bn by 2031, Growing at a 7.5% CAGR
The global Neuroprotection Market was valued at USD 31.6 Bn in 2022 and is projected to witness steady growth, expanding at a…
-
Date:
Botulinum Toxin Market to Reach USD 11.5 Billion by 2031, Driven by Rising Aesthetic Demand | Key Players: AbbVie, Ipsen, and Merz Pharma
The global Botulinum Toxin Market was valued at USD 6.1 billion in 2022 and is projected to reach USD 11.5 billion by…
-
Date:
Glaucoma Treatment Market to Reach USD 9.1 Billion by 2031, Led by Innovation from AbbVie, Novartis, and Santen Pharmaceutical
The global glaucoma treatment market was valued at USD 6.3 billion in 2022 and is projected to reach USD 9.1 billion by…
-
Date:
Global Antiseptic and Disinfectant Market to Reach USD 61.2 Billion by 2031 Amid Rising Hygiene Awareness
The global Antiseptic and Disinfectant Market was valued at USD 33.1 Bn in 2022 and is projected to reach USD 61.2 Bn…
-
Date:
Global Liposome Drug Delivery Market to Surpass USD 10.0 Billion by 2031 Amid Rising Demand for Targeted Therapies
The global Liposome Drug Delivery Market was valued at USD 4.7 billion in 2022 and is projected to surpass USD 10.0 billion…
-
Date:
Lung Disease Therapeutics Market to Surpass USD 109.4 Bn by 2031, Driven by Innovations from GSK, AstraZeneca, and Novartis
The global lung disease therapeutics market was valued at USD 76.5 billion in 2021 and is projected to surpass USD 109.4 billion…
-
Date:
Fusion Inhibitors Market to Surpass USD 7.2 Bn by 2031, Led by Gilead Sciences, Roche, and GlaxoSmithKline
The global fusion inhibitors market, valued at USD 295.3 million in 2021, is set for significant growth, projected to surpass USD 7.2…
Olivia
Carter
is a writer covering health, tech, lifestyle, and economic trends. She loves crafting engaging stories that inform and inspire readers.
